ArticleWorld journal of gastroenterology2025
Nab-paclitaxel plus capecitabine as a first-line regimen for advanced biliary tract cancers: Feasible or not feasible?
Jian-Qiang Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.